Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1966 1
1967 2
1972 1
1980 1
1981 1
2000 1
2001 2
2002 5
2003 4
2004 7
2005 10
2006 9
2007 13
2008 10
2009 12
2010 25
2011 23
2012 20
2013 26
2014 23
2015 25
2016 28
2017 21
2018 21
2019 38
2020 36
2021 45
2022 45
2023 38
2024 54
2025 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

524 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced movement disorders.
Mehta SH, Morgan JC, Sethi KD. Mehta SH, et al. Neurol Clin. 2015 Feb;33(1):153-74. doi: 10.1016/j.ncl.2014.09.011. Neurol Clin. 2015. PMID: 25432728 Free article. Review.
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.
Parkinson Study Group SURE-PD3 Investigators; Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB Jr, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T. Parkinson Study Group SURE-PD3 Investigators, et al. Among authors: mehta sh. JAMA. 2021 Sep 14;326(10):926-939. doi: 10.1001/jama.2021.10207. JAMA. 2021. PMID: 34519802 Free PMC article. Clinical Trial.
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.
Mastenbroek SE, Vogel JW, Collij LE, Serrano GE, Tremblay C, Young AL, Arce RA, Shill HA, Driver-Dunckley ED, Mehta SH, Belden CM, Atri A, Choudhury P, Barkhof F, Adler CH, Ossenkoppele R, Beach TG, Hansson O. Mastenbroek SE, et al. Among authors: mehta sh. Nat Commun. 2024 Jun 15;15(1):5133. doi: 10.1038/s41467-024-49402-x. Nat Commun. 2024. PMID: 38879548 Free PMC article.
Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study.
Heo M, Norton BL, Pericot-Valverde I, Mehta SH, Tsui JI, Taylor LE, Lum PJ, Feinberg J, Kim AY, Arnsten JH, Sprecht-Walsh S, Page K, Murray-Krezan C, Anderson J, Litwin AH; HERO Study Group. Heo M, et al. Among authors: mehta sh. J Hepatol. 2024 May;80(5):702-713. doi: 10.1016/j.jhep.2023.12.020. Epub 2024 Jan 17. J Hepatol. 2024. PMID: 38242324 Clinical Trial.
Paroxysmal dyskinesias.
Mehta SH, Morgan JC, Sethi KD. Mehta SH, et al. Curr Treat Options Neurol. 2009 May;11(3):170-8. doi: 10.1007/s11940-009-0020-x. Curr Treat Options Neurol. 2009. PMID: 19364451
Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO Study.
Litwin AH, Tsui JI, Heo M, Mehta SH, Taylor LE, Lum PJ, Feinberg J, Kim AY, Norton BL, Pericot-Valverde I, Arnsten J, Meissner P, Karasz A, McKee MD, Ward JW, Johnson N, Agyemang L, Stein ES, Thomas A, Borsuk C, Blalock KL, Wilkinson S, Wagner K, Carty J, Murray-Krezan C, Anderson J, Jacobsohn V, Luetkemeyer AF, Falade-Nwulia O, Groome M, Davies S, Costello K, Page K; HERO Study Group. Litwin AH, et al. Among authors: mehta sh. JAMA Netw Open. 2024 Aug 1;7(8):e2430024. doi: 10.1001/jamanetworkopen.2024.30024. JAMA Netw Open. 2024. PMID: 39186268 Free article. Clinical Trial.
Paraneoplastic movement disorders.
Mehta SH, Morgan JC, Sethi KD. Mehta SH, et al. Curr Neurol Neurosci Rep. 2009 Jul;9(4):285-91. doi: 10.1007/s11910-009-0043-4. Curr Neurol Neurosci Rep. 2009. PMID: 19515280 Review.
Nutrition and pregnancy.
Mehta SH. Mehta SH. Clin Obstet Gynecol. 2008 Jun;51(2):409-18. doi: 10.1097/GRF.0b013e31816fda53. Clin Obstet Gynecol. 2008. PMID: 18463470 Review.
Intrasaccular Treatment of Intracranial Aneurysms: A Comprehensive Review.
Shao MM, White TG, Bassett JB, Dowlati E, Mehta SH, Werner C, Golub D, Shah KA, Dehdashti AR, Teron I, Link T, Patsalides A, Woo HH. Shao MM, et al. Among authors: mehta sh. J Clin Med. 2024 Oct 16;13(20):6162. doi: 10.3390/jcm13206162. J Clin Med. 2024. PMID: 39458111 Free PMC article. Review.
Post-sequelae symptoms and comorbidities after COVID-19.
Duggal P, Penson T, Manley HN, Vergara C, Munday RM, Duchen D, Linton EA, Zurn A, Keruly JC, Mehta SH, Thomas DL. Duggal P, et al. Among authors: mehta sh. J Med Virol. 2022 May;94(5):2060-2066. doi: 10.1002/jmv.27586. Epub 2022 Jan 31. J Med Virol. 2022. PMID: 35032030 Free PMC article.
524 results